Tuna Mutis
11PUBLICATIONS
84CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos
|Nov 03, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.M R Seefat, D G J Cucchi, L van Boven
|Oct 06, 2025
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL.Hilma J van der Horst, Tamás Csikós, Marjolein Quik
|Aug 19, 2025
A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy.Wassilis S C Bruins, Febe Smits, Carolien Duetz
|Feb 28, 2025
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy.Charlotte L B M Korst, Sabrin Tahri, Carolien Duetz
|Sep 14, 2024
Enhancing Fc-mediated effector functions of monoclonal antibodies: The example of HexaBodies.Hilma J van der Horst, Tuna Mutis
Pageof 2
Frequent Collaborators
6 joint publications
Sonja Zweegman
4 joint publications
Wassilis S C Bruins
4 joint publications
A Vera de Jonge
3 joint publications
Niels W C J van de Donk
3 joint publications
Rosa Rentenaar
2 joint publications
Richard W J Groen
2 joint publications
Hilma J van der Horst
2 joint publications
Esther C W Breij
2 joint publications
Joost de Bruijn
2 joint publications
Huipin Yuan
